Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.27M | 12.73M | 15.94M | 32.66M | 49.75M | 44.35M |
Gross Profit | 7.98M | 8.14M | 9.56M | 13.69M | 16.39M | 12.71M |
EBITDA | 2.11M | 2.89M | 6.13M | 8.46M | 11.61M | 5.09M |
Net Income | 1.97M | 2.00M | 4.82M | 6.16M | 8.45M | 1.02M |
Balance Sheet | ||||||
Total Assets | 22.14M | 23.03M | 27.64M | 29.45M | 33.92M | 32.64M |
Cash, Cash Equivalents and Short-Term Investments | 19.28M | 18.57M | 21.19M | 11.06M | 9.21M | 4.59M |
Total Debt | 367.00K | 725.40K | 1.42M | 1.47M | 3.94M | 11.89M |
Total Liabilities | 4.16M | 3.82M | 5.82M | 6.90M | 12.89M | 19.70M |
Stockholders Equity | 17.99M | 19.21M | 21.82M | 22.55M | 21.03M | 12.95M |
Cash Flow | ||||||
Free Cash Flow | 4.03M | 2.06M | 4.76M | 8.57M | 16.44M | 6.71M |
Operating Cash Flow | 4.03M | 2.06M | 4.77M | 8.60M | 16.47M | 6.82M |
Investing Cash Flow | 388.00K | 677.27K | 898.61K | 445.79K | 41.78K | 71.25K |
Financing Cash Flow | -2.60M | -5.37M | 4.51M | -7.23M | -11.90M | -6.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | HK$18.64M | 1.62 | -80.18% | ― | 4.39% | ― | |
58 Neutral | HK$48.13M | 23.64 | 10.68% | 3.85% | -15.78% | -46.15% | |
56 Neutral | HK$13.54B | 4.87 | -5.76% | 5.64% | 8.06% | -42.52% | |
51 Neutral | HK$3.12B | ― | -16.87% | ― | -2.35% | -837.50% | |
40 Underperform | HK$50.45M | ― | ― | -15.26% | 27.67% | ||
39 Underperform | HK$60.73M | ― | ― | 98.29% | 65.99% | ||
39 Underperform | HK$146.48M | ― | -253.21% | ― | 79.84% | -219.70% |